SOLVONIS THERAPEUTICS PLC (SVNS) — research page

UK · uk-cm-kg/LSE/SVNS · as of 2026-11-06

Identity and listing

SOLVONIS THERAPEUTICS PLC is listed on the LSE Main Market under ticker SVNS, ISIN GB00BMD1Z199, LEI 2138005PH7OJRCRPUD88. Its security type is Corporate and its segment is SSQ3. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

field	value	source · read date
name	SOLVONIS THERAPEUTICS PLC	source · 2026-11-06
exchange	LSE Main Market	source · 2026-11-06
ticker	SVNS	source · 2026-11-06
ISIN	GB00BMD1Z199	source · 2026-11-06
LEI	2138005PH7OJRCRPUD88	source · 2026-11-09
security type	Corporate	source · 2026-11-06
segment	SSQ3	source · 2026-11-06
sector	Pharmaceuticals and Biotechnology [201030]	source · 2026-11-06
jurisdiction	England and Wales (Companies House jurisdiction field)	source · 2026-11-06
status	listed, not halted	source · 2026-11-09

The disclosure read

The record holds 32 filings in the twelve months from 2025-11-06 to 2026-11-06, on 32 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-06, 0 days before the record date, and is a newswire release. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days, across 892 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days, across 51 issuers. The issuer's 32 filings sit above the exchange median of 29.0 and below the sector median of 42. Its cadence gap of 9 days sits above both medians. Its latency of 0 days sits below both medians.

	filings	median gap between filing days	days from latest filing to as-of
this issuer	32	9	0
exchange median: LSE Main Market (892 issuers)	29	4	3
sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers)	42	6	4

date	type	filing
2026-11-06	newswire_release	Solvonis Therapeutics plc Announces US Patent Office Allows Ketamine Patent Across All Behavioural Addictions
2026-11-05	regulatory_announcement	US Patent Office allows ketamine patent
2026-10-30	director_dealing	Directorate change
2026-10-16	early_warning	Holding(s) in Company
2026-10-13	regulatory_announcement	MOU Reached with ICAD

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Kreston Reeves LLP. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.

Orderability

For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.

client category	outcome
elective professional client	`ACM-200`
eligible counterparty	`ACM-200`

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 3 research houses: Singer Capital Markets, Water Tower Research and Turner Pope Investments (TPI) Limited.

research house	analyst	source · read date
Singer Capital Markets		issuer page · 2026-11-12
Water Tower Research		issuer page · 2026-11-12
Turner Pope Investments (TPI) Limited		issuer page · 2026-11-12

Open research

The record holds 1 openly published research note: Water Tower Research, dated 2026-07-13.

date	publisher	note	kind
2026-07-13	Water Tower Research	SVNS: Pursuing Acute Intervention Rather Than Chronic Treatment of High-Burden CNS Conditions	issuer-sponsored

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensor	entitlement	title	date	source
none loaded

As-of depth

No years are sealed for this issuer, and the market's vintage is not sealed. The market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.

Sources

12 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1: https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2: https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/SVNS (identity.isin)
10.3: https://find-and-update.company-information.service.gov.uk/company/10776788 (identity.jurisdiction)
10.4: https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5: https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page (identity.sector)
10.6: https://mcp.uk-cm-kg.ai/events/LSE/SVNS (the disclosure lines)
10.7: https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8: https://find-and-update.company-information.service.gov.uk/company/10776788/filing-history/MzUyMzcxNjc5NWFkaXF6a2N4/document?format=pdf&download=0 (the auditor)
10.9: https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10: https://solvonis.com/investor-relations/analyst-coverage (coverage)
10.11: https://cdn.smartinsider.com/InternalAnnouncement/pdf/2026/07/13/47627131.pdf (open research)
10.12: https://mcp.uk-cm-kg.ai/record/LSE/SVNS (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BMD1Z199"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9e0e2cebc074c872.